Crossmark

Quantitative Assessment of Premium Rates for Clinical Usefulness in New Drug Price Calculation in Japan

Crossref DOI link: https://doi.org/10.1177/2168479017696270

Published Online: 2017-12-30

Published Print: 2017-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Takayama, Akane

Kobayashi, Eriko

Nakamura, Tetsuya

Narukawa, Mamoru
License Information

Text and Data Mining valid from 2017-09-01
More Information

Article History

Received: 5 October 2016

Accepted: 26 January 2017

First Online: 30 December 2017